Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen
Publikationen
Ergebnisse pro Seite:  10

Dahm, Katrin; Vijayarangakannan, Parthiban; Wollscheid, Hans-Peter et al.

Atypical MAPKs in cancer

FEBS JOURNAL. Bd. 292. H. 9. 2024 S. 2173-2188


Meuth, Sven G.; Wolff, Stephanie; Mueck, Anna et al.

Different Treatment Outcomes of Multiple Sclerosis Patients Receiving Ocrelizumab or Ofatumumab

ANNALS OF NEUROLOGY. Bd. 97. H. 3. 2024 S. 583-595


Echchannaoui, Hakim; Perreau, Matthieu; Schild, Hansjoerg et al.

Editorial: Understanding convergent evasion mechanisms in cancer and chronic infection: implications for immunotherapy

FRONTIERS IN IMMUNOLOGY. Bd. 15. 2024


Mikulicic, Snjezana; Shamun, Merha; Massenberg, Annika et al.

ErbB2/HER2 receptor tyrosine kinase regulates human papillomavirus promoter activity

FRONTIERS IN IMMUNOLOGY. Bd. 15. 2024


Mikulicic, Snjezana; Shamun, Merha; Massenberg, Annika et al.

ErbB2/HER2 receptor tyrosine kinase regulates human papillomavirus promoter activity (vol 15, :1335302, 2024)

FRONTIERS IN IMMUNOLOGY. Bd. 15. 2024


Chasseigneaux, Stephanie; Cochois-Guegan, Veronique; Lecorgne, Lucas et al.

Fasting upregulates the monocarboxylate transporter MCT1 at the rat blood-brain barrier through PPAR δ activation

FLUIDS AND BARRIERS OF THE CNS. Bd. 21. H. 1. 2024



Liu, X.; Lorenz, B.; Lukas, D. et al.

ICER expression on NKp46-positive NK cells/ILC1 controls immunity to cutaneous leishmaniasis

EXPERIMENTAL DERMATOLOGY. Bd. 33. H. 3. 2024


Lang, Franziska; Schroers, Barbara; Loewer, Martin et al.

Identification of neoantigens for individualized therapeutic cancer vaccines (vol 21, pg 261, 2022)

NATURE REVIEWS DRUG DISCOVERY. Bd. 23. H. 2. 2024 S. 156-156


Schild, Hansjoerg; Bopp, Tobias

Immunological foundations of neurological diseases

NERVENARZT. Bd. 95. H. 10. 2024 S. 894-908